17 OH progesterone ELISA with neonatal procedure
The new 17 OH Progesterone Elisa (# KAP1401) uses a new polyclonal antibody and provides a validated extraction procedure for newborns serum samples. Extraction of the newborns samples is highly recommended in order to avoid any potential cross reaction with the 17OH-pregnenolone sulfate present in high concentration in very young infants. The DIAsource assay has the unique advantage to provide in the CE-IVD instructions for use a validated extraction procedure in addition to the corresponding expected concentration for newborns, men and women samples. Moreover the assay offers flexibility as it can be used on serum and EDTA/Heparin plasma samples and is easily adaptable for open-system ELISA analysers. Lastly, the 24-month shelf-life allows end-users to store the kits for a long term period with no impact on the stability, quality and performance characteristics of the assay.